State Street’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.43M | Buy |
123,257
+103,204
| +515% | +$3.71M | ﹤0.01% | 2999 |
|
|
2025
Q1 | $358K | Buy |
20,053
+19,722
| +5,958% | +$353K | ﹤0.01% | 3680 |
|
|
2024
Q4 | $10.9K | Buy |
+331
| New | +$10.9K | ﹤0.01% | 4275 |
|
|
2024
Q2 | – | Sell |
-10
| Closed | -$5.81K | – | 4396 |
|
|
2024
Q1 | $5.81K | Hold |
10
| – | – | ﹤0.01% | 4349 |
|
|
2023
Q4 | $12.6K | Hold |
10
| – | – | ﹤0.01% | 4383 |
|
|
2023
Q3 | $17K | Hold |
10
| – | – | ﹤0.01% | 4461 |
|
|
2023
Q2 | $49.3K | Hold |
10
| – | – | ﹤0.01% | 4421 |
|
|
2023
Q1 | $115K | Buy |
10
+8
| +400% | +$92.2K | ﹤0.01% | 4277 |
|
|
2022
Q4 | $18.6K | Hold |
2
| – | – | ﹤0.01% | 4741 |
|
|
2022
Q3 | $25K | Hold |
2
| – | – | ﹤0.01% | 4793 |
|
|
2022
Q2 | $75K | Sell |
2
-10
| -83% | -$375K | ﹤0.01% | 4625 |
|
|
2022
Q1 | $1.71M | Buy |
12
+2
| +20% | +$286K | ﹤0.01% | 3626 |
|
|
2021
Q4 | $2.39M | Hold |
10
| – | – | ﹤0.01% | 3584 |
|
|
2021
Q3 | $3.99M | Buy |
10
+2
| +25% | +$799K | ﹤0.01% | 3349 |
|
|
2021
Q2 | $5.66M | Buy |
+8
| New | +$5.66M | ﹤0.01% | 3188 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3903 |
|
|
2017
Q1 | – | Hold |
0
| – | -$7K | – | 3672 |
|
|
2016
Q4 | – | Hold |
0
| – | -$11K | – | 3653 |
|
|
2016
Q3 | – | Hold |
0
| – | -$32K | – | 3576 |
|
|
2016
Q2 | – | Hold |
0
| – | -$39K | – | 3626 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3630 |
|